GDNF and Parkinson disease: Preliminary data from our research group’s animal experiments confirm that in the subacute MPTP mouse model of PD, GDNF levels are diminished in the PFC alongside a notable reduction in dopamine concentration28, a change that GDNF administration is capable of reversing.